These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21067271)

  • 41. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
    Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
    Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
    Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
    Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms].
    Wang HY; Zhang ZX
    Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer.
    Ma Y; Chen Y; Petersen I
    Pathol Res Pract; 2017 Apr; 213(4):333-338. PubMed ID: 28214209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression of tyrosine kinase Syk in breast cancer and their clinical significance].
    Ding YB; Wu ZY; Wang S; Fan P; Zha XM; Zheng W; Liu XA
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):137-9. PubMed ID: 15062056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory effects of syk transfection on lung cancer cell invasion.
    Peng CL; Zhang Y; Sun QF; Zhao YP; Hao YT; Zhao XG; Cong B
    Asian Pac J Cancer Prev; 2013; 14(5):3001-3. PubMed ID: 23803069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Methylation Status of miR-182 Promoter in Lung Cancer Cell Lines].
    Li Y; Sun Y; Ren F; Li Y; Liu M; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):260-5. PubMed ID: 25975295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens.
    Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D
    Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells.
    Guo D; Wu B; Yan J; Li X; Sun H; Zhou D
    Biochem Biophys Res Commun; 2012 Nov; 428(1):80-5. PubMed ID: 23047008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blockade of DNA methylation enhances the therapeutic effect of gefitinib in non-small cell lung cancer cells.
    Li XY; Wu JZ; Cao HX; Ma R; Wu JQ; Zhong YJ; Feng JF
    Oncol Rep; 2013 May; 29(5):1975-82. PubMed ID: 23440266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
    Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
    Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.
    Suzuki M; Sunaga N; Shames DS; Toyooka S; Gazdar AF; Minna JD
    Cancer Res; 2004 May; 64(9):3137-43. PubMed ID: 15126351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of HERC5 and its potential role in NSCLC progression.
    Wrage M; Hagmann W; Kemming D; Uzunoglu FG; Riethdorf S; Effenberger K; Westphal M; Lamszus K; Kim SZ; Becker N; Izbicki JR; Sandoval J; Esteller M; Pantel K; Risch A; Wikman H
    Int J Cancer; 2015 May; 136(10):2264-72. PubMed ID: 25353388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR.
    Shah JN; Shao G; Hei TK; Zhao Y
    BMC Cancer; 2008 Oct; 8():284. PubMed ID: 18834524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of placenta growth factor by promoter hypermethylation in human lung and colon carcinoma.
    Xu L; Jain RK
    Mol Cancer Res; 2007 Sep; 5(9):873-80. PubMed ID: 17704140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
    Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].
    Fang HL; Yu ZC; Zhu HB; Jin YT
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression.
    Zhao L; Li S; Gan L; Li C; Qiu Z; Feng Y; Li J; Li L; Li C; Peng W; Xu C; Wang Z; Hui T; Ren G; Tao Q; Xiang T
    J Cell Mol Med; 2016 May; 20(5):842-54. PubMed ID: 26843424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.